The novel approach of the medication represents a significant development in the handling of diabetes mellitus type 2. Different to existing therapies, tirzepatide affects dual pathways – GLP-1 and GIP – resulting https://tirzepatidepeptide358686.bloggadores.com/40773686/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment